JP2016510768A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510768A5
JP2016510768A5 JP2015561831A JP2015561831A JP2016510768A5 JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5 JP 2015561831 A JP2015561831 A JP 2015561831A JP 2015561831 A JP2015561831 A JP 2015561831A JP 2016510768 A5 JP2016510768 A5 JP 2016510768A5
Authority
JP
Japan
Prior art keywords
crystalline form
form suc
suc
impurities
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015561831A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510768A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2014/000272 external-priority patent/WO2014138812A1/en
Publication of JP2016510768A publication Critical patent/JP2016510768A/ja
Publication of JP2016510768A5 publication Critical patent/JP2016510768A5/ja
Pending legal-status Critical Current

Links

JP2015561831A 2013-03-15 2014-03-14 抗不安化合物の塩、共結晶及び多形 Pending JP2016510768A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798926P 2013-03-15 2013-03-15
US61/798,926 2013-03-15
PCT/AU2014/000272 WO2014138812A1 (en) 2013-03-15 2014-03-14 Salts, co-crystals, and polymorphs of an anxiolytic compound

Publications (2)

Publication Number Publication Date
JP2016510768A JP2016510768A (ja) 2016-04-11
JP2016510768A5 true JP2016510768A5 (enExample) 2017-04-20

Family

ID=51535621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015561831A Pending JP2016510768A (ja) 2013-03-15 2014-03-14 抗不安化合物の塩、共結晶及び多形

Country Status (9)

Country Link
US (2) US9745296B2 (enExample)
EP (1) EP2970247A4 (enExample)
JP (1) JP2016510768A (enExample)
CN (1) CN105492440A (enExample)
AU (2) AU2014231722B2 (enExample)
CA (1) CA2905570A1 (enExample)
HK (1) HK1220191A1 (enExample)
MX (1) MX2015013059A (enExample)
WO (1) WO2014138812A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6688434B2 (en) 2002-02-22 2004-02-10 Ecolab Inc. Conveyor and lubricating apparatus, lubricant dispensing device, and method for applying lubricant to conveyor
CN105541701A (zh) * 2015-12-11 2016-05-04 吉林大学珠海学院 以顺丁烯二酸为前驱体的去铁酮药物共晶及其制备方法
TWI765688B (zh) * 2015-12-15 2022-05-21 以色列商諾發測量儀器股份有限公司 用於測量圖案化結構之方法及拉曼光譜系統
WO2019109150A1 (en) * 2017-12-07 2019-06-13 Bionomics Limited Methods of treating agitation
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN114585362B (zh) 2019-09-23 2024-05-07 生态有限公司 治疗制剂及其用途
AU2023201463A1 (en) * 2023-03-08 2024-09-26 Bionomics Limited Method of treating social anxiety disorder
WO2025033432A1 (ja) * 2023-08-08 2025-02-13 株式会社明治 概日リズムの調整

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007502839A (ja) * 2003-08-21 2007-02-15 トランソラル ファーマシューティカルズ,インコーポレイティド 口腔粘膜を介して5−htアゴニストを運搬するための組成物及びその使用方法
JP5373613B2 (ja) 2006-10-16 2013-12-18 バイオノミクス リミテッド 新規な抗不安薬化合物
DE102006060598A1 (de) * 2006-12-21 2008-06-26 Merck Patent Gmbh Tetrahydrobenzoisoxazole
GB0706044D0 (en) * 2007-03-28 2007-05-09 Syngenta Ltd C0-Crystals
BR112012013365A2 (pt) * 2009-12-03 2016-03-01 Astrazeneca Ab co-cristal do composto, método para preparar um co-cristal do composto, composição farmacêutica, uso de um co-cristal do composto, e, método de tratamento de complicações trombóticas arteriais
EP2680842A4 (en) * 2011-03-02 2014-10-29 Bionomics Ltd METHOD FOR THE TREATMENT OF A DISEASE OR A SENSE OF THE CENTRAL NERVOUS SYSTEM
JP6055817B2 (ja) * 2011-05-12 2016-12-27 バイオノミックス リミテッド ナフチリジンの調製方法
AU2013204159B2 (en) * 2013-03-15 2015-05-07 Bionomics Limited A Crystalline Form of an Anxiolytic Compound

Similar Documents

Publication Publication Date Title
JP2016510768A5 (enExample)
JP2018115191A5 (enExample)
JP2021530565A5 (enExample)
JP2010516681A5 (enExample)
JP2018035160A5 (enExample)
JP2013032389A5 (enExample)
JP2013542261A5 (enExample)
JP2016190843A5 (enExample)
JP2018024682A5 (enExample)
JP2015512942A5 (enExample)
JP2016537346A5 (enExample)
EP4643945A3 (en) Neuroactive steroids and methods of use thereof
JP2014501282A5 (enExample)
JP2020502092A5 (enExample)
JP2015078230A5 (enExample)
SI2956452T1 (en) Heterocyclic amides as kinase inhibitors
JP2012513416A5 (enExample)
JP2017514910A5 (enExample)
JP2017527578A5 (enExample)
JP2015516427A5 (enExample)
JP2017528506A5 (enExample)
JP2014530818A5 (enExample)
JP2020502224A5 (enExample)
JP2016529315A5 (enExample)
JP2016510767A5 (enExample)